Topical Drug Delivery Market Size is valued at USD 208.25 billion in 2022 and is predicted to reach USD 418.70 billion by the year 2031 at a 8.1% CAGR during the forecast period for 2023-2031.
Key Industry Insights & Findings from the Report:
The application of drugs or therapeutic agents directly to the skin or mucous membranes for the targeted treatment of various medical problems is referred to as topical drug delivery. The increased incidence of skin conditions including psoriasis and eczema, as well as minor ailments like acne, are the main drivers of this market's expansion. Additionally, it is anticipated that the rising usage of medications to treat diabetic neuropathic pain and foot ulcers, as well as the rising occurrences of burn injuries, diabetes prevalence, and eye illnesses, would all contribute to the market growth. Moreover, the transdermal patch, a non-invasive method of drug delivery, has seen a rise in popularity and widespread use in the market.
The entire market is expected to develop as a result of this adoption pattern. The primary market driver is also believed to be the tendency towards self-care or self-treatment at the point of care.
However, lockdowns, travel restrictions, and other issues caused interruptions in the pharmaceutical supply chain. The pandemic caused numerous clinical trials for innovative medicine formulations or delivery technologies to be postponed or interrupted. This might have delayed the release of ground-breaking topical products.
The Topical Drug Delivery Market is categorized based on product, route of administration, and facility of use. The product category comprises semi-solid, solid, liquid, and transdermal products. The semi-solid formulations segment includes creams, ointments, lotions, gels, and pastes. By liquid formulations, the market is segmented into suspensions and solutions.
The solid formulations segment includes powders and suppositories. By liquid formulations, the market is segmented into suspensions and solutions. Based on transdermal products, the market is segmented as transdermal patches and transdermal semi-solids. Route of administration, the market category comprises ophthalmic drug delivery, rectal drug delivery, dermal drug delivery, vaginal drug delivery, and nasal drug delivery. Facility of use category includes homecare settings, hospitals clinics, burn centers, and other facilities.
The semi-solid formulations category is expected to hold a significant share of the global Topical Drug Delivery Market in 2022. The semi-solid medication segment will develop the fastest and be the largest market during the projection period due to reasons such as the ease of application of semi-solid medications and their capacity to deliver a broad variety of therapeutic molecules. Semi-solid formulations are practical for patients because they are simple to spread and apply to the skin. Higher patient acceptance and compliance are a result of their non-invasiveness and comfortable application.
The burn centers segment is projected to grow at a rapid rate in the global Topical Drug Delivery Market. The rise in the number of burn care facilities is due to the much higher risk of mortality and morbidity that are related to burn patients. For deep second- and third-degree burns, topical treatments include silver sulfadiazine cream, nanocrystalline silver dressings, mafenide acetate cream, and hypochlorous antiseptic solutions, which are recommended in burn centers. Therefore, the market offers prospects for growth as a result of the rise in burn care facilities.
The North America Topical Drug Delivery Market is expected to register the highest market share in terms of revenue in the near future. This is mainly due to rising demand for self-administered medications, greater preference for painless drug delivery, and the development of skin conditions. Moreover, the region's dominance is mostly due to the high frequency of skin illnesses and rising spending on topical dermatological products. However, during the forecast period, Asia-Pacific is anticipated to experience a significant growth rate. The Asia-Pacific topical medication delivery market has grown owing to the rising demand from developing nations like China and India, as well as an increase in the number of people with skin diseases.
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 208.25 Bn |
|
Revenue Forecast In 2031 |
USD 418.70 Bn |
|
Growth Rate CAGR |
CAGR of 8.1% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, Route Of Administration, And Facility Of Use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; South East Asia |
|
Competitive Landscape |
Galderma (Switzerland), Johnson & Johnson Private Limited (US), GlaxoSmithKline Plc. (UK), Glenmark Pharmaceuticals Ltd. (India), Rusan Pharma Ltd. (India), Bausch Health Companies Inc. (Canada), Hisamitsu Pharmaceuticals Inc. (Japan), Cipla (India), Bayer AG (Germany), Viatris Inc. (Mylan N.V.) (US), 3M (US), Merck & Co.Inc.. (Germany), Crescita Therpeautics Inc. (Canada), Novartis International AG (Switzerland), Boehringer Ingelheim International GmBH (Germany), Pfizer Inc. (US), Teva Pharmaceuticals Industries Ltd. (Israel), Bristol Myers Squibb (US), Lavipharm (Greece), AbbVie Inc. (US), CMP Pharma, Inc. (Germany), Encore Dermatology, Inc. (US), Prosolus Inc. (US), Lead Chemical Co., Ltd. (Japan), and Purdue Pharma L.P. (US). |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Topical Drug Delivery Market Snapshot
Chapter 4. Global Topical Drug Delivery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Product:
5.2.1. Semi-Solid Formulations
5.2.1.1. Creams
5.2.1.2. Ointments
5.2.1.3. Lotions
5.2.1.4. Gel
5.2.1.5. Pastes
5.2.2. Liquid Formulations
5.2.2.1. Suspensions
5.2.2.2. Solutions
5.2.3. Solid Formulations
5.2.3.1. Powders
5.2.3.2. Suppositories
5.2.4. Transdermal Products
5.2.4.1. Transdermal Patches
5.2.4.2. Transdermal Semi-Solids
Chapter 6. Market Segmentation 2: By Route of Administration Estimates & Trend Analysis
6.1. By Route of Administration & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Route of Administration:
6.2.1. Dermal Drug Delivery
6.2.2. Ophthalmic Drug Delivery
6.2.3. Rectal Drug Delivery
6.2.4. Vaginal Drug Delivery
6.2.5. Nasal Drug Delivery
Chapter 7. Market Segmentation 3: By Facility of Use Estimates & Trend Analysis
7.1. By Facility of Use & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Facility of Use:
7.2.1. Home Care Settings
7.2.2. Hospitals & Clinics
7.2.3. Burn Centers
7.2.4. Other Facilities
Chapter 8. Topical Drug Delivery Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Topical Drug Delivery Market revenue (US$ Million) estimates and forecasts By Product, 2019-2031
8.1.2. North America Topical Drug Delivery Market revenue (US$ Million) estimates and forecasts By Route of Administration, 2019-2031
8.1.3. North America Topical Drug Delivery Market revenue (US$ Million) estimates and forecasts By Facility of Use, 2019-2031
8.1.4. North America Topical Drug Delivery Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Topical Drug Delivery Market revenue (US$ Million) By Product, 2019-2031
8.2.2. Europe Topical Drug Delivery Market revenue (US$ Million) By Route of Administration, 2019-2031
8.2.3. Europe Topical Drug Delivery Market revenue (US$ Million) By Facility of Use, 2019-2031
8.2.4. Europe Topical Drug Delivery Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Topical Drug Delivery Market revenue (US$ Million) By Product, 2019-2031
8.3.2. Asia Pacific Topical Drug Delivery Market revenue (US$ Million) By Route of Administration, 2019-2031
8.3.3. Asia Pacific Topical Drug Delivery Market revenue (US$ Million) By Facility of Use, 2019-2031
8.3.4. Asia Pacific Topical Drug Delivery Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Topical Drug Delivery Market revenue (US$ Million) By Product, (US$ Million) 2019-2031
8.4.2. Latin America Topical Drug Delivery Market revenue (US$ Million) By Route of Administration, (US$ Million) 2019-2031
8.4.3. Latin America Topical Drug Delivery Market revenue (US$ Million) By Facility of Use, (US$ Million) 2019-2031
8.4.4. Latin America Topical Drug Delivery Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Topical Drug Delivery Market revenue (US$ Million) By Product, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Topical Drug Delivery Market revenue (US$ Million) By Route of Administration, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Topical Drug Delivery Market revenue (US$ Million) By Facility of Use, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Topical Drug Delivery Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. 3M
9.2.2. AbbVie Inc.
9.2.3. Bausch Health Companies Inc.
9.2.4. Bayer AG
9.2.5. Boehringer Ingelheim International GmBH
9.2.6. Bristol Myers Squibb
9.2.7. Cipla
9.2.8. CMP Pharma, Inc.
9.2.9. Crescita Therpeautics Inc.
9.2.10. Encore Dermatology, Inc.
9.2.11. Galderma
9.2.12. GlaxoSmithKline Plc.
9.2.13. Glenmark Pharmaceuticals Ltd.
9.2.14. Hisamitsu Pharmaceuticals Inc.
9.2.15. Johnson & Johnson Private Limited
9.2.16. Lavipharm
9.2.17. Lead Chemical Co., Ltd.
9.2.18. Merck & Co.Inc..
9.2.19. Novartis International AG
9.2.20. Pfizer Inc.
9.2.21. Prosolus Inc.
9.2.22. Purdue Pharma L.P.
9.2.23. Rusan Pharma Ltd.
By Product-
By Route of Administration-
By Facility of Use-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
